The use of a mixed-treatment comparison to assess the cost-effectiveness of OZURDEX (Dexamethasone 700 ?g intravitreal implant in applicator) compared with bevacizumab intravitreal injections for patients with Macular Oedema following Branch Retinal Vein Occlusion

Authors:

Almond C, Hayward E, Freemantle N and Brereton N.

Publication Type:

Conference Proceedings – Poster

Publication Name:

14th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress

Citation:

Almond C, Hayward E, Freemantle N and Brereton N. The use of a mixed-treatment comparison to assess the cost-effectiveness of OZURDEX®™ (Dexamethasone 700 μg intravitreal implant in applicator) compared with bevacizumab intravitreal injections for patients with Macular Oedema following Branch Retinal Vein Occlusion. 14th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress Madrid, Spain. 5-8 November 2011. Poster PSS26.


Link to publication ⟶

⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies